Preparation of stable tau oligomers for cellular and biochemical studies

Thomas K. Karikari, David A. Nagel, Alastair Grainger, Charlotte Clarke-bland, Eric J. Hill, Kevin G. Moffat

Research output: Contribution to journalArticle

Abstract

Increasing evidence suggests that small oligomers are the principal neurotoxic species of tau in Alzheimer's disease and other tauopathies. However, mechanisms of tau oligomer-mediated neurodegeneration are poorly understood. The transience of oligomers due to aggregation can compromise the stability of oligomers prepared in vitro. Consequently, we sought to develop an efficient method which maintains the stability and globular conformation of preformed oligomers. This study demonstrates that labeling a single-cysteine form of the pro-aggregant tau four-repeat region (K18) with either Alexa Fluor 488-C5-maleimide or N-ethylmaleimide in reducing conditions stabilizes oligomers by impeding their further aggregation. Furthermore, the use of this approach to study the propagation of labeled extracellular tau K18 oligomers into human neuroblastoma cells and human stem cell-derived neurons is described. This method is potentially applicable for preparing stabilized oligomers of tau for diagnostic and biomarker tests, as well as for in vitro structure-activity relationship assays.
Original languageEnglish
Pages (from-to)67-74
Number of pages8
JournalAnalytical Biochemistry
Volume566
Early online date11 Oct 2018
DOIs
Publication statusPublished - 1 Feb 2019

Fingerprint

Oligomers
Tauopathies
Ethylmaleimide
Structure-Activity Relationship
Neuroblastoma
Routine Diagnostic Tests
Cysteine
Alzheimer Disease
Stem Cells
Biomarkers
Neurons
Agglomeration
In Vitro Techniques
K-18 conjugate
Stem cells
Labeling
Conformations
Assays
Alexa Fluor 488 C5-maleimide

Bibliographical note

© 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/)

Funding: National Centre for the Replacement, Refinement and Reduction of Animals in Research (grant NC/C013101/1); Biotechnology and Biological Sciences Research Council grant number BB/J014532/1.

Keywords

  • Alzheimer's disease
  • iPSC-derived neurons
  • Maleimide
  • Oligomer
  • Tau
  • Tauopathies

Cite this

Karikari, Thomas K. ; Nagel, David A. ; Grainger, Alastair ; Clarke-bland, Charlotte ; Hill, Eric J. ; Moffat, Kevin G. / Preparation of stable tau oligomers for cellular and biochemical studies. In: Analytical Biochemistry. 2019 ; Vol. 566. pp. 67-74.
@article{2784a9bd8bdb40b4b54aa659122d522f,
title = "Preparation of stable tau oligomers for cellular and biochemical studies",
abstract = "Increasing evidence suggests that small oligomers are the principal neurotoxic species of tau in Alzheimer's disease and other tauopathies. However, mechanisms of tau oligomer-mediated neurodegeneration are poorly understood. The transience of oligomers due to aggregation can compromise the stability of oligomers prepared in vitro. Consequently, we sought to develop an efficient method which maintains the stability and globular conformation of preformed oligomers. This study demonstrates that labeling a single-cysteine form of the pro-aggregant tau four-repeat region (K18) with either Alexa Fluor 488-C5-maleimide or N-ethylmaleimide in reducing conditions stabilizes oligomers by impeding their further aggregation. Furthermore, the use of this approach to study the propagation of labeled extracellular tau K18 oligomers into human neuroblastoma cells and human stem cell-derived neurons is described. This method is potentially applicable for preparing stabilized oligomers of tau for diagnostic and biomarker tests, as well as for in vitro structure-activity relationship assays.",
keywords = "Alzheimer's disease, iPSC-derived neurons, Maleimide, Oligomer, Tau, Tauopathies",
author = "Karikari, {Thomas K.} and Nagel, {David A.} and Alastair Grainger and Charlotte Clarke-bland and Hill, {Eric J.} and Moffat, {Kevin G.}",
note = "{\circledC} 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/) Funding: National Centre for the Replacement, Refinement and Reduction of Animals in Research (grant NC/C013101/1); Biotechnology and Biological Sciences Research Council grant number BB/J014532/1.",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.ab.2018.10.013",
language = "English",
volume = "566",
pages = "67--74",
journal = "Analytical Biochemistry",
issn = "0003-2697",
publisher = "Academic Press Inc.",

}

Preparation of stable tau oligomers for cellular and biochemical studies. / Karikari, Thomas K.; Nagel, David A.; Grainger, Alastair; Clarke-bland, Charlotte; Hill, Eric J.; Moffat, Kevin G.

In: Analytical Biochemistry, Vol. 566, 01.02.2019, p. 67-74.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Preparation of stable tau oligomers for cellular and biochemical studies

AU - Karikari, Thomas K.

AU - Nagel, David A.

AU - Grainger, Alastair

AU - Clarke-bland, Charlotte

AU - Hill, Eric J.

AU - Moffat, Kevin G.

N1 - © 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/) Funding: National Centre for the Replacement, Refinement and Reduction of Animals in Research (grant NC/C013101/1); Biotechnology and Biological Sciences Research Council grant number BB/J014532/1.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Increasing evidence suggests that small oligomers are the principal neurotoxic species of tau in Alzheimer's disease and other tauopathies. However, mechanisms of tau oligomer-mediated neurodegeneration are poorly understood. The transience of oligomers due to aggregation can compromise the stability of oligomers prepared in vitro. Consequently, we sought to develop an efficient method which maintains the stability and globular conformation of preformed oligomers. This study demonstrates that labeling a single-cysteine form of the pro-aggregant tau four-repeat region (K18) with either Alexa Fluor 488-C5-maleimide or N-ethylmaleimide in reducing conditions stabilizes oligomers by impeding their further aggregation. Furthermore, the use of this approach to study the propagation of labeled extracellular tau K18 oligomers into human neuroblastoma cells and human stem cell-derived neurons is described. This method is potentially applicable for preparing stabilized oligomers of tau for diagnostic and biomarker tests, as well as for in vitro structure-activity relationship assays.

AB - Increasing evidence suggests that small oligomers are the principal neurotoxic species of tau in Alzheimer's disease and other tauopathies. However, mechanisms of tau oligomer-mediated neurodegeneration are poorly understood. The transience of oligomers due to aggregation can compromise the stability of oligomers prepared in vitro. Consequently, we sought to develop an efficient method which maintains the stability and globular conformation of preformed oligomers. This study demonstrates that labeling a single-cysteine form of the pro-aggregant tau four-repeat region (K18) with either Alexa Fluor 488-C5-maleimide or N-ethylmaleimide in reducing conditions stabilizes oligomers by impeding their further aggregation. Furthermore, the use of this approach to study the propagation of labeled extracellular tau K18 oligomers into human neuroblastoma cells and human stem cell-derived neurons is described. This method is potentially applicable for preparing stabilized oligomers of tau for diagnostic and biomarker tests, as well as for in vitro structure-activity relationship assays.

KW - Alzheimer's disease

KW - iPSC-derived neurons

KW - Maleimide

KW - Oligomer

KW - Tau

KW - Tauopathies

UR - https://linkinghub.elsevier.com/retrieve/pii/S0003269718305244

UR - http://www.scopus.com/inward/record.url?scp=85056822925&partnerID=8YFLogxK

U2 - 10.1016/j.ab.2018.10.013

DO - 10.1016/j.ab.2018.10.013

M3 - Article

VL - 566

SP - 67

EP - 74

JO - Analytical Biochemistry

JF - Analytical Biochemistry

SN - 0003-2697

ER -